The China Mail - Japan drugmaker reports two more deaths in supplement scare

USD -
AED 3.672335
AFN 70.999951
ALL 84.750286
AMD 384.440139
ANG 1.789623
AOA 915.999683
ARS 1142.265019
AUD 1.547075
AWG 1.8
AZN 1.7318
BAM 1.70054
BBD 2.018225
BDT 122.241013
BGN 1.70578
BHD 0.377332
BIF 2941
BMD 1
BND 1.284404
BOB 6.921917
BRL 5.487797
BSD 0.999591
BTN 86.385177
BWP 13.489614
BYN 3.271192
BYR 19600
BZD 2.007878
CAD 1.37253
CDF 2876.999784
CHF 0.820984
CLF 0.02458
CLP 943.260604
CNY 7.189396
CNH 7.194355
COP 4070.22
CRC 504.562627
CUC 1
CUP 26.5
CVE 96.124962
CZK 21.675502
DJF 177.720179
DKK 6.513165
DOP 59.349767
DZD 130.66271
EGP 50.550403
ERN 15
ETB 134.800226
EUR 0.87317
FJD 2.25795
FKP 0.740032
GBP 0.746935
GEL 2.719922
GGP 0.740032
GHS 10.306428
GIP 0.740032
GMD 71.500677
GNF 8655.999814
GTQ 7.676624
GYD 209.04866
HKD 7.84983
HNL 26.149985
HRK 6.576601
HTG 131.092379
HUF 352.33597
IDR 16407
ILS 3.486905
IMP 0.740032
INR 86.662202
IQD 1310
IRR 42124.999871
ISK 125.229768
JEP 0.740032
JMD 158.933315
JOD 0.709037
JPY 145.208985
KES 129.19551
KGS 87.450302
KHR 4019.999959
KMF 427.475643
KPW 899.963608
KRW 1381.010058
KWD 0.30648
KYD 0.833054
KZT 519.309107
LAK 21574.999659
LBP 89599.999887
LKR 300.305627
LRD 199.650448
LSL 17.920522
LTL 2.95274
LVL 0.60489
LYD 5.419866
MAD 9.158502
MDL 17.118088
MGA 4425.0001
MKD 53.682112
MMK 2099.347973
MNT 3582.393265
MOP 8.08048
MRU 39.720029
MUR 45.840037
MVR 15.404982
MWK 1736.000015
MXN 19.06779
MYR 4.259497
MZN 63.949775
NAD 17.920227
NGN 1546.869657
NIO 36.749953
NOK 10.013625
NPR 138.211728
NZD 1.674817
OMR 0.3845
PAB 0.99957
PEN 3.596507
PGK 4.12125
PHP 57.481009
PKR 283.55003
PLN 3.736175
PYG 7977.775266
QAR 3.640498
RON 4.390298
RSD 102.368977
RUB 78.498684
RWF 1425
SAR 3.752014
SBD 8.354365
SCR 14.175341
SDG 600.4977
SEK 9.68169
SGD 1.288245
SHP 0.785843
SLE 22.502271
SLL 20969.503664
SOS 571.50433
SRD 38.850209
STD 20697.981008
SVC 8.746158
SYP 13001.640893
SZL 17.940086
THB 32.8975
TJS 10.045431
TMT 3.5
TND 2.935497
TOP 2.342098
TRY 39.537885
TTD 6.776979
TWD 29.589502
TZS 2635.000192
UAH 41.675673
UGX 3599.640036
UYU 40.840105
UZS 12709.999734
VES 102.556698
VND 26122.5
VUV 119.866292
WST 2.629628
XAF 570.345316
XAG 0.027392
XAU 0.000298
XCD 2.70255
XDR 0.709327
XOF 567.497048
XPF 104.224976
YER 242.700597
ZAR 18.09694
ZMK 9001.192811
ZMW 23.964628
ZWL 321.999592
  • CMSC

    0.0900

    22.314

    +0.4%

  • CMSD

    0.0250

    22.285

    +0.11%

  • RBGPF

    0.0000

    69.04

    0%

  • SCS

    0.0400

    10.74

    +0.37%

  • RELX

    0.0300

    53

    +0.06%

  • RIO

    -0.1400

    59.33

    -0.24%

  • GSK

    0.1300

    41.45

    +0.31%

  • NGG

    0.2700

    71.48

    +0.38%

  • BP

    0.1750

    30.4

    +0.58%

  • BTI

    0.7150

    48.215

    +1.48%

  • BCC

    0.7900

    91.02

    +0.87%

  • JRI

    0.0200

    13.13

    +0.15%

  • VOD

    0.0100

    9.85

    +0.1%

  • BCE

    -0.0600

    22.445

    -0.27%

  • RYCEF

    0.1000

    12

    +0.83%

  • AZN

    -0.1200

    73.71

    -0.16%

Japan drugmaker reports two more deaths in supplement scare
Japan drugmaker reports two more deaths in supplement scare / Photo: © AFP

Japan drugmaker reports two more deaths in supplement scare

A Japanese drugmaker whose dietary supplements are at the centre of a growing health scare reported on Thursday two more deaths potentially related to its tablets.

Text size:

Last week, Kobayashi Pharmaceutical recalled three supplement brands -- "Beni Koji Choleste Help" and two others -- after customer complaints of kidney problems.

The over-the-counter products contain an ingredient called red yeast rice, or "beni koji", which is supposed to help lower cholesterol.

Thursday's announcement brings the total number of deaths under investigation by the company and health ministry to four, with more than 100 other people hospitalised.

"We were told yesterday by a bereaved family that a person who had been using Choleste Help had passed away due to kidney disease," the drugmaker said in a statement.

It added it had been told separately that another person who had used Choleste Help in recent years had died.

"We are in the process of confirming the facts and causal relationships in both of these cases," the statement said.

"However, we decided to make this report public from the viewpoint of prompt disclosure."

Medical studies describe red yeast rice as an alternative to statins for lowering high cholesterol, but also warn of a risk of organ damage depending on its chemical make-up.

Kobayashi Pharmaceutical sells a wide range of health products marketed through television adverts in Japan.

The Osaka-based company says it has also supplied red yeast rice to around 50 other firms in Japan and two in Taiwan.

Government spokesman Yoshimasa Hayashi said Thursday that authorities were doing "their utmost to ensure food safety, including identifying the substance that caused the health harm and how it became present in the product".

The government has ordered various health-food makers to review their products, while informing foreign countries about the issue through Japan's embassies, he said.

Dozens of Japanese firms that used beni koji provided by Kobayashi Pharmaceutical have also separately announced recalls.

The affected products include health tablets as well as a rose-coloured sparkling sake, salad dressing, bread and miso paste used in many traditional dishes.

Kobayashi Pharmaceutical has said analysis had found a possibility that the products contained "ingredients we had not intended to include".

But it said it did not find any citrinin produced by red yeast rice, which is toxic and can damage the kidneys.

R.Lin--ThChM